1. Optimized immunohistochemistry using the D5F3 antibody provides a reliable test for identification of ALK-positive lung adenocarcinomas
- Author
-
Gian Luca Rampioni Vinciguerra, Flavio Fochetti, Benedetto Pini, Luigi Ruco, Claudia Cippitelli, and Stefania Scarpino
- Subjects
0301 basic medicine ,Adult ,Male ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Adenocarcinoma of Lung ,In situ hybridization ,Biology ,Adenocarcinoma ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Biomarkers, Tumor ,Anaplastic lymphoma kinase ,Humans ,Anaplastic Lymphoma Kinase ,Prospective Studies ,Prospective cohort study ,Molecular Biology ,In Situ Hybridization, Fluorescence ,Aged ,Lung ,Antibodies, Monoclonal ,Receptor Protein-Tyrosine Kinases ,Histology ,Cell Biology ,General Medicine ,Middle Aged ,medicine.disease ,Immunohistochemistry ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,biology.protein ,Female ,Antibody - Abstract
We used optimized immunohistochemistry (IHC) with the D5F3 antibody for detection of tumours in a prospective study of 307 pulmonary adenocarcinomas. Cases positive by IHC (1+, 2+, 3+) were further investigated by fluorescent in situ hybridization (FISH). Of 307 cases, 22 (7.2%) were moderately intensely positive (2+/3+); 18 of these (82%) were also positive by FISH. Of the four IHC-positive/FISH-negative cases, one was unsuitable for FISH and three had abnormalities of the ALK gene. All cases with weak reactivity with D5F3 (1+) were FISH-negative. The FISH positive/IHC-positive cases with moderately intense reactivity had the typical clinicopathologic features of ALK-positive patients (younger age, p
- Published
- 2016